Search Results - "Zlatnik, E Yu"

Refine Results
  1. 1

    Difference in serum cytokines between metastatic colorectal cancer patients with mutant and wild type RAS in response to targeted treatment with monoclonal antibodies by Zlatnik, E. Yu, Sagakyants, A. B., Vladimirova, L. Yu, Tishina, A. V.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (27-07-2024)
    “…Cytokines and chemokines play dual – pro- and antioncogenic – roles in tumor progression. Targeted medications of monoclonal antibodies, anti-VEGF…”
    Get full text
    Journal Article
  2. 2

    Immunohistochemical parameters of serous ovarian carcinomas and possible mechanism of development of resistance to platinum-based drugs by Zhukova, G. V., Ulyanova, E. P., Menshenina, A. P., Moiseenko, T. I., Zlatnik, E. Yu, Nepomnyashchaya, E. M., Sagakyants, A. B., Verenikina, E. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (07-09-2024)
    “…The aim of the study was to evaluate a prognostic significance of immunohistochemical parameters in serous ovarian carcinomas and their statistical…”
    Get full text
    Journal Article
  3. 3

    PD-1 and LAG-3 as early prognostic markers in the treatment of patients with chronic lymphocytic leukemia by Selyutina, O. N., Lysenko, I. B., Guskova, N. K., Novikova, I. А., Zlatnik, E. Yu, Pushkareva, T. F., Nikolaeva, N. V., Kamaeva, I. A., Kapuza, E. A., Gaysultanova, Ya. S., Rozenko, L. Ya

    Published in Onkogematologii͡a (08-12-2023)
    “…Background. Recently, studies have been conducted all over the world to study the role of immune checkpoints in the pathogenesis of chronic lymphocytic…”
    Get full text
    Journal Article
  4. 4

    Molecular and cellular aspects of the impact of secondary metabolites from common barberry and hybrid goat’s rue on the HeLa cell line by E. Yu. Zlatnik, Ya. S. Enin, O. N. Burov, E. S. Bondarenko, A. B. Sagakyants, D. S. Kutilin, Yu. V. Dzigunova, O. G. Ishonina, E. V. Shalashnaya, N. D. Ushakova

    Published in Issledovaniâ i praktika v medicine (01-12-2023)
    “…Purpose of the study. To isolate and verify pure fractions of secondary plant metabolites contained in B. vulgaris (L.) and P. hibridus (L.), as well as to…”
    Get full text
    Journal Article
  5. 5

    Interrelation between Pseudomonas aeruginosa quinolone signal and the level of immunoglobulins in the blood of patients with lung cancer by Shestopalov, A. V., Кit, O. I., Davydov, V. V., Baizyanova, Ya. M., Zlatnik, E. Yu, Novikova, I. A., Sagakyants, A. B., Appolonova, S. A., Moskaleva, N. E., Rumyantsev, S. A.

    Published in Uspehi molekulârnoj onkologii (10-07-2023)
    “…Introduction . Researchers in the field of oncology have a significant interest in the role of microorganisms in development of malignant neoplasms. Aim . To…”
    Get full text
    Journal Article
  6. 6

    Local cytokine levels as prognostic factors for early relapse of non-muscle-invasive bladder carcinoma by Zlatnik, E. Yu, Sagakyants, A. B., Shulgina, O. G., Shevchenko, A. N., Filatova, E. V., Belyakova, L. I., Breus, A. A., Maslov, A. A., Maslov, A. A., Rozenko, L. Ya

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-06-2023)
    “…The aim of our study is to assess the local cytokine levels as prognostic factors for early relapse in NMIBC patients. 75 patients with NMIBC were enrolled in…”
    Get full text
    Journal Article
  7. 7

    Characteristics of local and system immunity, and features of cancer stem cells in patients with different stage, dynamics and prognosis of colorectal carcinoma by Zlatnik, E. Yu, Novikova, I. A., Bondarenko, E. S., Uljanova, E. P., Sitkovskaya, A. O.

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (10-03-2022)
    “…Clinical prognosis in malignant tumors` is among the most challenging problems of contemporary medicine. It is thought to depend on both biologic properties of…”
    Get full text
    Journal Article
  8. 8

    Expression of LAG-3 on B-lymphocytes as a marker for prediction of response to therapy in patients with chronic lymphocytic leukemia by Selyutina, O. N., Lysenko, I. B., Guskova, N. K., Novikova, I. A., Zlatnik, E. Yu, Pushkareva, T. F., Nikolaeva, N. V., Kamaeva, I. A., Samaneva, N. Yu, Kapuza, E. A.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (01-05-2023)
    “…Purpose : to study the level of LAG-3 expression on B-lymphocytes and the feasibility of using it as a marker for predicting response to therapy in patients…”
    Get full text
    Journal Article
  9. 9

    Metabolism of tryptophan in non-small lung cancer patients with different effect of PD-1 / PD-L1 inhibitors immunotherapy by Zlatnik, E. Yu, Sagakyants, A. B., Novikova, I. A., Maksimov, A. Yu, Shatova, O. P., Appolonova, S. A., Moskaleva, N. E., Rumyantsev, S. A., Shestopalov, A. V.

    Published in Uspehi molekulârnoj onkologii (26-06-2022)
    “…Introduction. In the structure of cancer incidence, lung cancer ranks first among men. In order to study the molecular mechanisms of the initiation and…”
    Get full text
    Journal Article
  10. 10

    Generation of Lymphokine-Activated Killers on the Background of a Decresed Content of T-regulatory Cells In Vitro by Sitkovskaya, A. O., Zlatnik, E. Yu, Shamova, T. V., Bondarenko, E. S., Novikova, I. A., Vaschenko, L. N., Kechedzhieva, E. E., Dashkova, I. R., Ausheva, T. V., Kit, O. I.

    Published in Cell and tissue biology (01-09-2021)
    “…In this work we studied the effect of different concentrations of interleukin-2 (IL-2) and interferon-γ (IFN-γ) on the proliferation and immunophenotype of…”
    Get full text
    Journal Article
  11. 11

    Comparative analysis of some immunological parameters depending on the tumor location on the right and left sides of colon by Kit, O. I., Dzhenkova, E. A., Mirzoyan, E. A., Sagakyants, A. B., Zlatnik, E. Yu, Bondarenko, E. S., Novikova, I. A., Maslov, A. A.

    Published in Innovacionnaâ medicina Kubani (Online) (21-09-2022)
    “…Background: Colorectal cancer is now an urgent problem in oncology. Recently, specialists have been interested in a comparative analysis of differences in the…”
    Get full text
    Journal Article
  12. 12

    Humanized animals as models of experimental oncology (review) by Kit, O. I., Zhukova, G. V., Maksimov, A. Yu, Goncharova, A. S., Zlatnik, E. Yu, Lukbanova, L. A.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (13-01-2022)
    “…The humanization of immunodeficient animals allows us to study the growth of xenografts of human malignant tumors and their response to therapeutic effects,…”
    Get full text
    Journal Article
  13. 13

    Evaluation of Toll-like receptors expression in terms of colon cancer by E. A. Dzhenkova, E. A. Mirzoyan, A. B. Sagakyants, E. S. Bondarenko, E. Yu. Zlatnik, A. V. Shaposhnikov, E. N. Kolesnikov, O. Yu. Kaymakchi, A. V. Dashkov, G. V. Kaminskiy, A. G. Milakin, S. A. Malinin, D. A. Savchenko, L. Kh. Chalkhakhyan

    Published in Issledovaniâ i praktika v medicine (01-12-2022)
    “…Purpose of the study. To evaluate the number of cells with the CD45+/- phenotype expressing Toll-like receptors (TLRs) in tissues of the tumor, peritumoral…”
    Get full text
    Journal Article
  14. 14

    Newcastle disease virus - effective alliance in the fight against cancer by Sitkovskaya, A. O., Zlatnik, E. Yu, Novikova, I. A., Kit, O. I.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (01-01-2019)
    “…Cancer is still the leading cause of death in developed countries. Oncolytic virus (OV) therapy is a promising new strategy for tumor growth inhibition…”
    Get full text
    Journal Article
  15. 15

    ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW) by Kit, O. I., Ignatov, S. N., Zlatnik, E. Yu, Soldatkina, N. V., Rostorguev, E. E., Sagakyants, A. B., Bondarenko, E. S., Sitkovskaya, A. O.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (31-12-2020)
    “…Glial tumors comprise about 60 % of primary malignant brain tumors, and 70 % of them show morphological signs of high-grade cancer (High Grade Gliomas III , IV…”
    Get full text
    Journal Article
  16. 16

    INDIVIDUAL PROGNOSTIC ALGORITHM FOR ESTIMATING THE RISK OF ESOPHAGEAL CANCER PROGRESSION AFTER SURGICAL TREATMENT by Kit, O. I., Zlatnik, E. Yu, Bazaev, A. L., Demidova, A. A., Novikova, I. A.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (29-10-2020)
    “…The development of laboratory criteria for predicting esophageal cancer (EC) prognosis is of great importance due to the need to achieve personalized approach…”
    Get full text
    Journal Article
  17. 17
  18. 18

    FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER by Sagakyants, A. B., Kit, O. I., Ulyanova, E. P., Zlatnik, E. Yu, Novikova, I. A., Shulgina, O. G., Gevorkyan, Yu. A., Soldatkina, N. V., Samoylenko, N. S., Dzhenkova, E. A., Shaposhnikov, A. V.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (06-03-2021)
    “…Background . Gastric cancer is the second leading cause of cancer-related death due to advanced disease. A special role in the pathogenesis and metastasis of…”
    Get full text
    Journal Article
  19. 19

    Effect of monochromatic light of low intensity on L929 skin fibroblast culture by Sheiko, E A, Shikhlyarova, A I, Zlatnik, E Yu, Zakora, G I, Ivanenko, E S

    “…Effects of exposure to low-intensity monochromatic red spectrum radiation in different modes were studied on L929 skin fibroblast culture. Radiometric and…”
    Get full text
    Journal Article
  20. 20

    The Effect of Oncolytic Reovirus P-92 on Dendritic Cell Maturation and Generation of Tumor-Specific Lymphocytes in vitro by Sitkovskaya, A. O., Zlatnik, E. Yu, Mezhevova, I. V., Bondarenko, E. S., Kolpakov, S. A., Kolpakova, E. P., Novikova, I. A.

    Published in Cell and tissue biology (2019)
    “…Utilization of oncolytic viruses (OVs) is a promising approach to inhibit the tumor growth. OVs exhibit both direct antitumor and indirect immunostimulatory…”
    Get full text
    Journal Article